IFG Advisory’s Immunogen Inc IMGN Stock Holding History

IFG Advisory’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,110	Closed	-$46.5K	–	519
2023 Q1	$46.5K	Hold	12,110	–	–	﹤0.01%	505
2022 Q4	$60K	Buy	+12,110	New	+$65.7K	0.01%	482

Other funds holding IMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IFG Advisory's IMGN Position: Q2 2023 in Review

IFG Advisory sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 12,110 shares — an estimated $46.5K sold.

IFG Advisory first reported a position in IMGN in Q4 2022 and held it in 2 quarters. The position peaked at $60K in Q4 2022. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

IFG Advisory reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
IFG Advisory sold 12,110 Immunogen Inc shares in Q2 2023, an estimated $46.5K.
IFG Advisory first reported a position in Immunogen Inc in Q4 2022 and held it in 2 quarters.
IFG Advisory's Immunogen Inc position peaked at $60K in Q4 2022.
266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on IFG Advisory's 13F filing for Q2 2023, filed 21 Jul 2023.